These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 30547803

  • 1. Cyclin G2 suppresses Wnt/β-catenin signaling and inhibits gastric cancer cell growth and migration through Dapper1.
    Gao J, Zhao C, Liu Q, Hou X, Li S, Xing X, Yang C, Luo Y.
    J Exp Clin Cancer Res; 2018 Dec 14; 37(1):317. PubMed ID: 30547803
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex.
    Deng YZ, Yao F, Li JJ, Mao ZF, Hu PT, Long LY, Li G, Ji XD, Shi S, Guan DX, Feng YY, Cui L, Li DS, Liu Y, Du X, Guo MZ, Xu LY, Li EM, Wang HY, Xie D.
    Gastroenterology; 2012 Apr 14; 142(4):812-823.e15. PubMed ID: 22240482
    [Abstract] [Full Text] [Related]

  • 4. Cyclin G2 regulates canonical Wnt signalling via interaction with Dapper1 to attenuate tubulointerstitial fibrosis in diabetic nephropathy.
    Zhao C, Gao J, Li S, Liu Q, Hou X, Xing X, Wang D, Sun M, Wang S, Luo Y.
    J Cell Mol Med; 2020 Mar 14; 24(5):2749-2760. PubMed ID: 31978940
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Forkhead Box F2 Suppresses Gastric Cancer through a Novel FOXF2-IRF2BPL-β-Catenin Signaling Axis.
    Higashimori A, Dong Y, Zhang Y, Kang W, Nakatsu G, Ng SSM, Arakawa T, Sung JJY, Chan FKL, Yu J.
    Cancer Res; 2018 Apr 01; 78(7):1643-1656. PubMed ID: 29374064
    [Abstract] [Full Text] [Related]

  • 7. Silencing of WISP3 suppresses gastric cancer cell proliferation and metastasis and inhibits Wnt/β-catenin signaling.
    Fang F, Zhao WY, Li RK, Yang XM, Li J, Ao JP, Jiang SH, Kong FZ, Tu L, Zhuang C, Qin WX, He P, Zhang WM, Cao H, Zhang ZG.
    Int J Clin Exp Pathol; 2014 Apr 01; 7(10):6447-61. PubMed ID: 25400723
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. RHBDD1 Promotes the Growth and Stemness Characteristics of Gastric Cancer Cells by Activating Wnt/β-catenin Signaling Pathway.
    Yang Y, Yuan Y, Xia B.
    Curr Stem Cell Res Ther; 2024 Apr 01; 19(7):1021-1028. PubMed ID: 37861049
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. TRIM58 suppresses the tumor growth in gastric cancer by inactivation of β-catenin signaling via ubiquitination.
    Liu X, Long Z, Cai H, Yu S, Wu J.
    Cancer Biol Ther; 2020 Apr 01; 21(3):203-212. PubMed ID: 31747856
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-338 inhibits proliferation, migration, and invasion of gastric cancer cells by the Wnt/β-catenin signaling pathway.
    Song B, Lin HX, Dong LL, Ma JJ, Jiang ZG.
    Eur Rev Med Pharmacol Sci; 2018 Mar 01; 22(5):1290-1296. PubMed ID: 29565486
    [Abstract] [Full Text] [Related]

  • 20. Tumor Inhibitory Effect of Long Non-coding RNA LOC100505817 on Gastric Cancer.
    Zheng L, Kang L, Cheng Y, Cao J, Liu L, Xu H, Gao L.
    Pathol Oncol Res; 2021 Mar 01; 27():581542. PubMed ID: 34385891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.